Literature DB >> 16041408

Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection.

Pauline Soulas1, Anne Woods, Benoit Jaulhac, Anne-Marie Knapp, Jean-Louis Pasquali, Thierry Martin, Anne-Sophie Korganow.   

Abstract

Autoantibody production during infections is considered to result from nonspecific activation of low-affinity autoreactive B cells. Whether this can lead to autoimmune disease remains uncertain. We show that chronic infection by Borrelia burgdorferi of Tg animals expressing human rheumatoid factor (RF) B cells (of low or intermediate affinities) in the absence or in the constitutive presence of the autoantigen (represented here by chimeric IgG with human constant region) breaks their state of immunological ignorance, leading to the production of RFs. Surprisingly, this production was more pronounced in intermediate-affinity RF Tg mice co-expressing the autoantigen. This overproduction was mediated by immune complexes and involved synergistic signaling between the B cell receptor and Toll-like receptors and T cell help. These findings indicate that chronic infection can activate autoreactive B cells with significant affinity and creates conditions that can drive them to differentiate into memory cells. Such cells may have some physiological yet undetermined role, but in autoimmune-prone individuals, this scenario may initiate autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041408      PMCID: PMC1177998          DOI: 10.1172/JCI24646

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.

Authors:  M Y Sangster; D J Topham; S D'Costa; R D Cardin; T N Marion; L K Myers; P C Doherty
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Dual reactivity of several monoclonal anti-nucleosome autoantibodies for double-stranded DNA and a short segment of histone H3.

Authors:  C Stemmer; P Richalet-Sécordel; M van Bruggen; K Kramers; J Berden; S Muller
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

3.  Comparison of rheumatoid factors of rheumatoid arthritis patients, of individuals with mycobacterial infections and of normal controls: evidence for maturation in the absence of an autoimmune response.

Authors:  N Djavad; S Bas; X Shi; J Schwager; M Jeannet; T Vischer; E Roosnek
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

4.  B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.

Authors:  J Anguita; R Roth; S Samanta; R J Gee; S W Barthold; M Mamula; E Fikrig
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.

Authors:  L Yang; Y Ma; R Schoenfeld; M Griffiths; E Eichwald; B Araneo; J J Weis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Organ-specific disease provoked by systemic autoimmunity.

Authors:  V Kouskoff; A S Korganow; V Duchatelle; C Degott; C Benoist; D Mathis
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

7.  Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies.

Authors:  Y R Zou; W Müller; H Gu; K Rajewsky
Journal:  Curr Biol       Date:  1994-12-01       Impact factor: 10.834

8.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  In vivo polyclonal B-lymphocyte activation elicited by murine viruses.

Authors:  J P Coutelier; P G Coulie; P Wauters; H Heremans; J T van der Logt
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.

Authors:  E Roosnek; A Lanzavecchia
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  15 in total

1.  Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus.

Authors:  Jun Yamagami; Stephen Kacir; Ken Ishii; Aimee S Payne; Don L Siegel; John R Stanley
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

Review 2.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

Review 3.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

5.  Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.

Authors:  Amina Toumi; Marwah Adly Saleh; Jun Yamagami; Olfa Abida; Maryem Kallel; Abderrahmen Masmoudi; Sondes Makni; Hamida Turki; Takahisa Hachiya; Keiko Kuroda; John R Stanley; Hatem Masmoudi; Masayuki Amagai
Journal:  J Dermatol Sci       Date:  2013-02-19       Impact factor: 4.563

6.  Autoimmune response to transthyretin in juvenile idiopathic arthritis.

Authors:  Cristina C Clement; Halima Moncrieffe; Aditi Lele; Ginger Janow; Aniuska Becerra; Francesco Bauli; Fawzy A Saad; Giorgio Perino; Cristina Montagna; Neil Cobelli; John Hardin; Lawrence J Stern; Norman Ilowite; Steven A Porcelli; Laura Santambrogio
Journal:  JCI Insight       Date:  2016-02-25

7.  Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance.

Authors:  Anne Woods; Fanny Monneaux; Pauline Soulas-Sprauel; Sylviane Muller; Thierry Martin; Anne-Sophie Korganow; Jean-Louis Pasquali
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Rashidah M Green; Svetlana Marukian; Andrew H Talal; Gerond V Lake-Bakaar; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

9.  Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).

Authors:  Elena Lorente; Miguel G Fontela; Eilon Barnea; Antonio J Martín-Galiano; Carmen Mir; Begoña Galocha; Arie Admon; Pilar Lauzurica; Daniel López
Journal:  Mol Cell Proteomics       Date:  2020-04-07       Impact factor: 5.911

10.  MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection.

Authors:  Anne Woods; Pauline Soulas-Sprauel; Benoit Jaulhac; Bérénice Arditi; Anne-Marie Knapp; Jean-Louis Pasquali; Anne-Sophie Korganow; Thierry Martin
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.